![Paul van Damme](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul van Damme
Direttore/Membro del Consiglio presso XORTX THERAPEUTICS INC.
Patrimonio netto: 18 308 $ in data 31/05/2024
Posizioni attive di Paul van Damme
Società | Posizione | Inizio | Fine |
---|---|---|---|
XORTX THERAPEUTICS INC. | Direttore/Membro del Consiglio | 25/01/2018 | - |
Independent Dir/Board Member | 25/01/2018 | - | |
Wildlaw Capital Markets, Inc.
![]() Wildlaw Capital Markets, Inc. Investment ManagersFinance Wildlaw Capital Markets, Inc. provides investment advice. The private company is based in Toronto, Canada. | Corporate Officer/Principal | - | - |
Ontario Genomics Institute | Direttore/Membro del Consiglio | 20/10/2010 | - |
WD Capital Markets, Inc.
![]() WD Capital Markets, Inc. Finance/Rental/LeasingFinance WD Capital Markets, Inc. provides equity and debt financing services. The private company is based in Toronto, Canada. | Corporate Officer/Principal | - | - |
Storia della carriera di Paul van Damme
Precedenti posizioni note di Paul van Damme
Società | Posizione | Inizio | Fine |
---|---|---|---|
MIND MEDICINE (MINDMED) INC. | Direttore Finanziario/CFO | 28/02/2020 | 01/04/2020 |
OncoQuest, Inc.
![]() OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | Direttore/Membro del Consiglio | 01/11/2015 | 01/02/2020 |
Structural Genomics Consortium
![]() Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services The Structural Genomics Consortium is a non-profit organization that accelerates research by sharing all of its research output with the scientific community without any restrictions. The private company is based in Headington, UK. The British company has created an open collaborative network of scientists in hundreds of universities worldwide and nine pharmaceutical companies. The company was founded by Pär Nordlund. | Direttore/Membro del Consiglio | 01/01/2012 | 31/05/2019 |
Direttore Finanziario/CFO | 01/01/2012 | 31/05/2019 | |
Segretario Aziendale | 01/01/2012 | 31/05/2019 | |
GALAXY DIGITAL HOLDINGS LTD. | Direttore Finanziario/CFO | - | 31/07/2018 |
Bradmer Pharmaceuticals, Inc.
![]() Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Direttore Finanziario/CFO | 12/09/2007 | 01/07/2018 |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Paul van Damme
Rotman School of Management | Masters Business Admin |
University of Toronto | Undergraduate Degree |
Statistiche
Distribuzione geografica
Canada | 23 |
Stati Uniti | 3 |
Sud Africa | 2 |
Posizioni
Director of Finance/CFO | 14 |
Director/Board Member | 8 |
Corporate Officer/Principal | 4 |
Settori
Health Technology | 9 |
Commercial Services | 7 |
Finance | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
APTOSE BIOSCIENCES INC. | Health Technology |
QUEST PHARMATECH INC. | Commercial Services |
XORTX THERAPEUTICS INC. | Health Technology |
GALAXY DIGITAL HOLDINGS LTD. | Commercial Services |
MIND MEDICINE (MINDMED) INC. | Health Technology |
Aziende private | 19 |
---|---|
PricewaterhouseCoopers, Inc.
![]() PricewaterhouseCoopers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers, Inc. is a South African company that provides accounting, auditing, and bookkeeping services. The company is based in Sunninghill, South Africa. | Commercial Services |
Bradmer Pharmaceuticals, Inc.
![]() Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
Vasogen, Inc.
![]() Vasogen, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are research and commercialization of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It's lead product, the Celacade System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is currently being marketed in Europe by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage development for the treatment of chronic heart failure in the United States. It is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class. | Health Technology |
Canada Systems Group Ltd. | |
Ontario Genomics Institute | |
NXA, Inc.
![]() NXA, Inc. Other Metals/MineralsNon-Energy Minerals NXA, Inc. engages in the exploration of base materials and precious metals. The company was founded on April 1, 1996 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
Ontario Genomics Institute (Private Equity)
![]() Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
Allelix Biopharmaceuticals, Inc. | Health Technology |
Laidlaw, Inc. (Connecticut) | Transportation |
ZipLocal, Inc.
![]() ZipLocal, Inc. Financial ConglomeratesFinance ZipLocal, Inc. is a development stage company. It operates through Canada geographical segments. The company was founded on August 22, 2005 and is headquartered in Toronto, Canada. | Finance |
Junior Achievement of Central Ontario
![]() Junior Achievement of Central Ontario Investment Trusts/Mutual FundsMiscellaneous Junior Achievement of Central Ontario educates young people about business. It focuses on work readiness, financial literacy and entrepreneurship, giving students the confidence and skills they need to become the next generation of business and community leaders. The company was founded by Horace A. Moses in 1919 and is headquartered in Toronto, Canada. | Miscellaneous |
Insception Biosciences, Inc.
![]() Insception Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Insception Biosciences, Inc. engages in the research and development of stem cell-based treatments. It also provides cord blood banking services. The company was founded by Robert Casper in 1996 and is headquartered in Mississauga, Canada. | Commercial Services |
Wildlaw Capital Markets, Inc.
![]() Wildlaw Capital Markets, Inc. Investment ManagersFinance Wildlaw Capital Markets, Inc. provides investment advice. The private company is based in Toronto, Canada. | Finance |
Structural Genomics Consortium
![]() Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services The Structural Genomics Consortium is a non-profit organization that accelerates research by sharing all of its research output with the scientific community without any restrictions. The private company is based in Headington, UK. The British company has created an open collaborative network of scientists in hundreds of universities worldwide and nine pharmaceutical companies. The company was founded by Pär Nordlund. | Commercial Services |
Crosswinds Holdings, Inc.
![]() Crosswinds Holdings, Inc. BiotechnologyHealth Technology Crosswinds Holdings, Inc. is a private equity and asset management company, which engages in the investment in the financial services sector. It operates through the following segments: Primary Insurance, Reinsurance, and Asset Management. The Primary Insurance segment invests in the Monarch National Insurance Company which is a property and casualty insurance carrier. The Reinsurance segment provides specialty reinsurance through Crosswinds Re. The Asset Management segment operates as an investment advisor through Crosswinds AUM LLC. The company was founded by John Fenbar Driscoll on March 29, 2005 and is headquartered in Toronto, Canada. | Health Technology |
OncoQuest, Inc.
![]() OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | Health Technology |
XORTX Pharma Corp.
![]() XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Health Technology |
Ellipsiz Communications Ltd.
![]() Ellipsiz Communications Ltd. Specialty TelecommunicationsCommunications Ellipsiz Communications Ltd. engages in the operations support for communication service provider. It also includes mobile network providers, fixed line telephone operators, cable operators, and internet service providers. The company was founded on April 1, 1996 and is headquartered in Markham, Canada. | Communications |
WD Capital Markets, Inc.
![]() WD Capital Markets, Inc. Finance/Rental/LeasingFinance WD Capital Markets, Inc. provides equity and debt financing services. The private company is based in Toronto, Canada. | Finance |
- Borsa valori
- Insiders
- Paul van Damme
- Esperienza